Evidence map›Paper›PMID 32021466›Full record

ArticleClinical epidemiology2020

Fasting Serum Levels of Potassium and Sodium in Relation to Long-Term Risk of Cancer in Healthy Men.

Ragnhild S Falk, Trond Heir, Trude E Robsahm, Steinar Tretli, Leiv Sandvik, Jan E Erikssen, Jan E Paulsen

Open access · goldAbstract read
In one paragraph

Article in Clinical epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ragnhild S FalkOslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.ORCID 0000-0001-8398-3492
Trond HeirOslo Ischemia study, Oslo University Hospital, Oslo, Norway.
Trude E RobsahmDepartment of Research, Cancer Registry of Norway, Oslo, Norway.ORCID 0000-0002-1652-7734
Steinar TretliDepartment of Research, Cancer Registry of Norway, Oslo, Norway.ORCID 0000-0002-2116-0041
Leiv SandvikOslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.
Jan E ErikssenOslo Ischemia study, Oslo University Hospital, Oslo, Norway.
Jan E PaulsenDepartment of Food Safety and Infection Biology, Norwegian University of Life Sciences, Oslo, Norway.ORCID 0000-0001-8775-0012
Oslo University Hospital · NOCancer Registry of Norway · NONorwegian University of Life Sciences · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo examine whether serum levels of potassium and sodium were associated with long-term cancer risk in initially healthy men. PATIENTS AND

methodsA cohort of 1994 initially healthy men with no use of medication, aged 40-59 years, was followed for cancer during 40 years of follow-up. Associations between fasting electrolyte levels and cancer risk were assessed with incidence rates and Cox proportional hazards models.

resultsPotassium, but not sodium, was linearly associated with cancer risk. This association remained significant after adjustment of several potential confounding factors, and also after excluding the first 10 years of follow-up. The age-adjusted risk of all-site cancer increased with 16% for each SD increase in potassium level. Men with hyperkalemia showed an incidence rate that was 40% higher than for men with normal potassium levels.

conclusionFasting serum potassium level in healthy men was positively associated with long-term cancer risk. Potassium or potassium ion channels may have a role in cell proliferation or differentiation. These findings might imply future cancer strategies for targeting individuals with high serum potassium levels.

Indexed as

cancer incidencecell proliferationelectrolyte levelsepidemiologyprospective cohort study

Identifiers

PMID32021466
PMCPMC6959139
OpenAlexW2999949468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.